tiprankstipranks

Syngene International Updates on Tax Litigation Developments

Story Highlights
  • Syngene operates in biotechnology, offering contract research and manufacturing services.
  • Syngene faces increased tax demand of Rs. 118.9 crore, impacting financial position.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Syngene International Updates on Tax Litigation Developments

Syngene International Ltd. ( (IN:SYNGENE) ) has provided an announcement.

Syngene International Ltd. has announced an update regarding its ongoing tax litigation for the assessment year 2018-19. The Deputy Commissioner of Income Tax has issued a revised order, increasing the tax demand to approximately Rs. 118.9 crore. The company is currently analyzing the order and plans to take appropriate action. This development may impact Syngene’s financial position and requires careful consideration by stakeholders.

More about Syngene International Ltd.

Syngene International Ltd. operates in the biotechnology industry, offering a range of services including contract research and manufacturing. The company focuses on providing integrated scientific solutions to the pharmaceutical, biotechnology, and agrochemical sectors.

YTD Price Performance: -18.56%

Average Trading Volume: 42,319

Current Market Cap: 288B INR

See more data about SYNGENE stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App